Literature DB >> 9182877

Immunons revisited: binding of multivalent antigens to B cells.

B Sulzer1, A S Perelson.   

Abstract

The T-independent B cell response induced by highly multivalent hapten polymer preparations has been studied extensively. The in vitro measured dose-response curve tends to be roughly bell-shaped with the peak response occurring at very low ligand concentrations, between 0.1-1 ng/ml for a variety of different ligands. Furthermore, polymers with more than approximately 10 haptens tend to be stimulatory, whereas polymers with fewer than 10 haptens conjugated, tend to be inhibitory. These observations have been perplexing when viewed within the context of standard theories of receptor ligation by multivalent ligands. We present a new analysis of these previous experiments that reconciles the differences between theory and experiment. From this theory it is concluded that the peak in the observed dose response curve only weakly reflects properties of the ligand and the affinity of surface immunoglobulin for the hapten, but depends strongly on the density of antigen-specific B cells in the culture. The number of responding cells decreases at low ligand concentrations, because cells have to share limiting amounts of ligand and not because of the decreasing probability of receptors and ligands meeting each other. Our theory leads to the same conclusion as made by previous researchers, namely that a minimum number of receptor sites, of the order of 10, need to be bound to a single ligand in order to stimulate a B cell. While this conclusion was based on the lack of immunogenicity of antigens carrying less than a minimum number of haptens, the quantitative results of this study, derived from fitting experimental dose response curves obtained with highly multivalent antigens, provide evidence for the immunon hypothesis that is based upon the degree of receptor aggregation. Our theory also provides quantitative agreement with experimental observations on systems, in which both stimulatory and non-stimulatory polymers are mixed in the same system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182877     DOI: 10.1016/s0161-5890(96)00096-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  Steric effects on multivalent ligand-receptor binding: exclusion of ligand sites by bound cell surface receptors.

Authors:  W S Hlavacek; R G Posner; A S Perelson
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

Review 2.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

Review 3.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

4.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

Review 5.  A review of quantitative modeling of B cell responses to antigenic challenge.

Authors:  Timothy P Hickling; Xiaoying Chen; Paolo Vicini; Satyaprakash Nayak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-19       Impact factor: 2.745

6.  Supramolecular complexing of membane Siglec CD22 mediated by a polyvalent heterobifunctional ligand that templates on IgM.

Authors:  Lina Cui; Pavel I Kitov; Gladys C Completo; James C Paulson; David R Bundle
Journal:  Bioconjug Chem       Date:  2011-03-23       Impact factor: 4.774

7.  Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP.

Authors:  Tamar Canello; Kati Frid; Ronen Gabizon; Silvia Lisa; Assaf Friedler; Jackob Moskovitz; María Gasset; Ruth Gabizon
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

8.  In vitro reconstitution of B cell receptor-antigen interactions to evaluate potential vaccine candidates.

Authors:  Grant C Weaver; Rina F Villar; Masaru Kanekiyo; Gary J Nabel; John R Mascola; Daniel Lingwood
Journal:  Nat Protoc       Date:  2016-01-07       Impact factor: 13.491

9.  Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.

Authors:  Carlos A Velikovsky; Fernando A Goldbaum; Juliana Cassataro; Silvia Estein; Raúl A Bowden; Laura Bruno; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 10.  Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists.

Authors:  Matthew Black; Amanda Trent; Matthew Tirrell; Colleen Olive
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.